Global Oncology Drugs Market Insights, Forecast to 2025

  • ID:PD038886
  • August 2019
  • QY Research
                          

Oncology Drugs Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast period 2019-2025. The Global Oncology Drugs Industry Report gives an elaborate information about the market size, share and analyzes the complete value chain the report also covers the market dynamics enriching business strategists with quality data about the Oncology Drugs market.

Oncology Drugs is widely used For Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer and Other Cancer Treatment. The most proportion of Oncology Drugs used for Blood Cancer and the proportion in 2017 is 22.74%.

The global Oncology Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Oncology Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Oncology Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oncology Drugs in these regions.

This research report categorizes the global Oncology Drugs market by top players/brands, region, type and end user. This report also studies the global Oncology Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

  • Roche
  • HENGRUI
  • AstraZeneca
  • QILU
  • Sanofi
  • HANSOH
  • LUYE
  • Novartis
  • GuiZhou YiBai
  • Lunan
  • Eli Lilly and Company

Market size by Product

  • Antimetabolite
  • Alkaloid drugs
  • Hormone
  • Targeted drug
  • Platinum-based drugs
  • Other
  • Market size by End User
  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Respiratory/Lung Cancer
  • Other

Market size by Region

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Singapore
  • Malaysia
  • Philippines
  • Thailand
  • Vietnam
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Central & South America
  • Brazil
  • Rest of Central & South America
  • Middle East & Africa
  • GCC Countries
  • Turkey
  • Egypt
  • South Africa

The study objectives of this report are:

  • To study and analyze the global Oncology Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
  • To understand the structure of Oncology Drugs market by identifying its various subsegments.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • Focuses on the key global Oncology Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
  • To project the value and sales volume of Oncology Drugs submarkets, with respect to key regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Table of Contents

1 Study Coverage

1.1 Oncology Drugs Product

1.2 Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Oncology Drugs Market Size Growth Rate by Product

1.4.2 Antimetabolite

1.4.3 Alkaloid drugs

1.4.4 Hormone

1.4.5 Targeted drug

1.4.6 Platinum-based drugs

1.4.7 Other

1.5 Market by End User

1.5.1 Global Oncology Drugs Market Size Growth Rate by End User

1.5.2 Blood Cancer

1.5.3 Breast Cancer

1.5.4 Gastrointestinal Cancer

1.5.5 Prostate Cancer

1.5.6 Respiratory/Lung Cancer

1.5.7 Other

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Oncology Drugs Market Size

2.1.1 Global Oncology Drugs Revenue 2014-2025

2.1.2 Global Oncology Drugs Sales 2014-2025

2.2 Oncology Drugs Growth Rate by Regions

2.2.1 Global Oncology Drugs Sales by Regions

2.2.2 Global Oncology Drugs Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Oncology Drugs Sales by Manufacturers

3.1.1 Oncology Drugs Sales by Manufacturers

3.1.2 Oncology Drugs Sales Market Share by Manufacturers

3.1.3 Global Oncology Drugs Market Concentration Ratio (CR5 and HHI)

3.2 Oncology Drugs Revenue by Manufacturers

3.2.1 Oncology Drugs Revenue by Manufacturers (2014-2019)

3.2.2 Oncology Drugs Revenue Share by Manufacturers (2014-2019)

3.3 Oncology Drugs Price by Manufacturers

3.4 Oncology Drugs Manufacturing Base Distribution, Product Types

3.4.1 Oncology Drugs Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Oncology Drugs Product Type

3.4.3 Date of International Manufacturers Enter into Oncology Drugs Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Oncology Drugs Sales by Product

4.2 Global Oncology Drugs Revenue by Product

4.3 Oncology Drugs Price by Product

5 Breakdown Data by End User

5.1 Overview

5.2 Global Oncology Drugs Breakdown Data by End User

6 North America

6.1 North America Oncology Drugs by Countries

6.1.1 North America Oncology Drugs Sales by Countries

6.1.2 North America Oncology Drugs Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Oncology Drugs by Product

6.3 North America Oncology Drugs by End User

7 Europe

7.1 Europe Oncology Drugs by Countries

7.1.1 Europe Oncology Drugs Sales by Countries

7.1.2 Europe Oncology Drugs Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Oncology Drugs by Product

7.3 Europe Oncology Drugs by End User

8 Asia Pacific

8.1 Asia Pacific Oncology Drugs by Countries

8.1.1 Asia Pacific Oncology Drugs Sales by Countries

8.1.2 Asia Pacific Oncology Drugs Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Oncology Drugs by Product

8.3 Asia Pacific Oncology Drugs by End User

9 Central & South America

9.1 Central & South America Oncology Drugs by Countries

9.1.1 Central & South America Oncology Drugs Sales by Countries

9.1.2 Central & South America Oncology Drugs Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Oncology Drugs by Product

9.3 Central & South America Oncology Drugs by End User

10 Middle East and Africa

10.1 Middle East and Africa Oncology Drugs by Countries

10.1.1 Middle East and Africa Oncology Drugs Sales by Countries

10.1.2 Middle East and Africa Oncology Drugs Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Oncology Drugs by Product

10.3 Middle East and Africa Oncology Drugs by End User

11 Company Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Company Business Overview

11.1.3 Roche Oncology Drugs Sales, Revenue and Gross Margin (2014-2019)

11.1.4 Roche Oncology Drugs Products Offered

11.1.5 Roche Recent Development

11.2 HENGRUI

11.2.1 HENGRUI Company Details

11.2.2 Company Business Overview

11.2.3 HENGRUI Oncology Drugs Sales, Revenue and Gross Margin (2014-2019)

11.2.4 HENGRUI Oncology Drugs Products Offered

11.2.5 HENGRUI Recent Development

11.3 AstraZeneca

11.3.1 AstraZeneca Company Details

11.3.2 Company Business Overview

11.3.AstraZeneca Oncology Drugs Sales, Revenue and Gross Margin (2014-2019)

11.3.4 AstraZeneca Oncology Drugs Products Offered

11.3.5 AstraZeneca Recent Development

11.4 QILU

11.4.1 QILU Company Details

11.4.2 Company Business Overview

11.4.3 QILU Oncology Drugs Sales, Revenue and Gross Margin (2014-2019)

11.4.4 QILU Oncology Drugs Products Offered

11.4.5 QILU Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Details

11.5.2 Company Business Overview

11.5.3 Sanofi Oncology Drugs Sales, Revenue and Gross Margin (2014-2019)

11.5.4 Sanofi Oncology Drugs Products Offered

11.5.5 Sanofi Recent Development

11.6 HANSOH

11.6.1 HANSOH Company Details

11.6.2 Company Business Overview

11.6.3 HANSOH Oncology Drugs Sales, Revenue and Gross Margin (2014-2019)

11.6.4 HANSOH Oncology Drugs Products Offered

11.6.5 HANSOH Recent Development

11.7 LUYE

11.7.1 LUYE Company Details

11.7.2 Company Business Overview

11.7.3 LUYE Oncology Drugs Sales, Revenue and Gross Margin (2014-2019)

11.7.4 LUYE Oncology Drugs Products Offered

11.7.5 LUYE Recent Development

11.8 Novartis

11.8.1 Novartis Company Details

11.8.2 Company Business Overview

11.8.3 Novartis Oncology Drugs Sales, Revenue and Gross Margin (2014-2019)

11.8.4 Novartis Oncology Drugs Products Offered

11.8.5 Novartis Recent Development

11.9 GuiZhou YiBai

11.9.1 GuiZhou YiBai Company Details

11.9.2 Company Business Overview

11.9.3 GuiZhou YiBai Oncology Drugs Sales, Revenue and Gross Margin (2014-2019)

11.9.4 GuiZhou YiBai Oncology Drugs Products Offered

11.9.5 GuiZhou YiBai Recent Development

11.10 Lunan

11.10.1 Lunan Company Details

11.10.2 Company Business Overview

11.10.3 Lunan Oncology Drugs Sales, Revenue and Gross Margin (2014-2019)

11.10.4 Lunan Oncology Drugs Products Offered

11.10.5 Lunan Recent Development

11.11 Eli Lilly and Company

12 Future Forecast

12.1 Oncology Drugs Market Forecast by Regions

12.1.1 Global Oncology Drugs Sales Forecast by Regions 2019-2025

12.1.2 Global Oncology Drugs Revenue Forecast by Regions 2019-2025

12.2 Oncology Drugs Market Forecast by Product

12.2.1 Global Oncology Drugs Sales Forecast by Product 2019-2025

12.2.2 Global Oncology Drugs Revenue Forecast by Product 2019-2025

12.3 Oncology Drugs Market Forecast by End User

12.4 North America Oncology Drugs Forecast

12.5 Europe Oncology Drugs Forecast

12.6 Asia Pacific Oncology Drugs Forecast

12.7 Central & South America Oncology Drugs Forecast

12.8 Middle East and Africa Oncology Drugs Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis

14.2 Oncology Drugs Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Insights, Forecast to 2025

Tigecycline Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global Caffeine Market Insights, Forecast to 2025

Caffeine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast  read more..


Global Rabies Vaccine Market Insights, Forecast to 2025

Rabies Vaccine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


United States Parkinsons Disease Drug Market Report 2018-2025

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers,  read more..


Global Radiopharmaceuticals Market Insights, Forecast to 2025

Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Neurorehabilitation System Market Research Report

The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and  read more..


Global High Acuity Care Information Systems Market Research Report

The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also  read more..